Neuropathology & Targeted Molecular Testing Core

$400,155P50FY2016AGNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 39677464 Paper 39666240 Paper 39444005 Paper 39402379 Paper 39402332 Paper 39379761 Paper 39371140 Paper 39345521 Paper 39254167 Paper 39234651 Paper 39231932 Paper 39207439 Paper 39173101 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38942763 Paper 38903124 Paper 38883718 Paper 38848188 Paper 38747387 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38244935 Paper 38244079 Paper 38215191 Paper 38194584 Paper 38014121 Paper 37762325 Paper 37745545 Paper 37606973 Paper 37605362 Paper 37592813 Paper 37580727 Paper 37578203 Paper 37563872 Paper 37547016 Paper 37528055 Paper 37491248 Paper 37338127 Paper 37322115 Paper 37292975 Paper 37292694 Paper 37260021 Paper 37248328 Paper 37245492 Paper 37212114 Paper 37141452 Paper 37125552 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36946449 Paper 36840665 Paper 36758620 Paper 36722399 Paper 36710669 Paper 36692179 Paper 36681388 Paper 36648159 Paper 36641671 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36564192 Paper 36530083 Paper 36524738 Paper 36482861 Paper 36453775 Paper 36450991 Paper 36394443 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36289000 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36223053 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36164936 Paper 36099407 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36031904 Paper 36031892

Abstract

CORE D: NPTMT ABSTRACT The Neuropathology and Targeted Molecular Testing (NPTMT) Core has been a valuable and frequently utilized resource for UW ADRC as it pursues its vision of precision medicine for Alzheimer's disease (AD) as well as for local and national AD research. The mission and thus, specific aims, have not significantly changed from the current award: (i) provide diagnostic expertise, (ii) provide targeted biomarker and genetic testing, (iii) build a highly accessible repository of brain tissue and fluid, (iv) develop innovative approaches, and (v) maintain a rich training environment. All of our research activities are focused on enhancing the research value of tissue and body fluid donations from cognitively healthy individuals and those in the early stages of AD while ensuring proper safeguards.

View original record on NIH RePORTER →